Financial Management Professionals
ANIP icon

Financial Management Professionals’s ANI Pharmaceuticals ANIP Stock Holding History

Financial Management Professionals’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-247
Closed -$20.4K – 1053
2026
Q2 		$20.4K Hold
247
– – ﹤0.01% 447
2026
Q1 		$19K Hold
247
– – ﹤0.01% 418
2025
Q4 		$19.5K Hold
247
– – ﹤0.01% 417
2025
Q3 		$22.6K Buy
+247
New +$20.1K ﹤0.01% 382

Other funds holding ANIP

Marathon Capital Management
Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
Kendall Capital Management
Kendall Capital Management Rockville, Maryland $605M AUM 38.16% 1-Year Est. Return
Samalin Investment Counsel
Samalin Investment Counsel Chappaqua, New York $319M AUM 12.97% 1-Year Est. Return

Financial Management Professionals's ANIP Position: Q3 2026 in Review

Financial Management Professionals sold out of ANI Pharmaceuticals (ANIP) in Q3 2026, closing a stake of 247 shares — an estimated $20.4K sold.

Financial Management Professionals first reported a position in ANIP in Q3 2025 and held it in 4 quarters. The position peaked at $22.6K in Q3 2025. 39 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Financial Management Professionals reported no remaining ANI Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Financial Management Professionals sold 247 ANI Pharmaceuticals shares in Q3 2026, an estimated $20.4K.
  • Financial Management Professionals first reported a position in ANI Pharmaceuticals in Q3 2025 and held it in 4 quarters.
  • Financial Management Professionals's ANI Pharmaceuticals position peaked at $22.6K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Financial Management Professionals's 13F filing for Q3 2026, filed 23 Oct 2026.